Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 430.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.651%)
Open: 440.00
High: 445.00
Low: 440.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Apr 2008 07:01

Tristel PLC04 April 2008 Tristel plc ("Tristel" or "the Company") Director Share Purchase Tristel plc, the AIM listed provider of infection and contamination controlproducts, announces that on the 3rd April 2008 Peter Stephens, Chairman of theRemuneration Committee and Non-Executive Director, purchased 25,000 OrdinaryShares in the Company at 39 pence per share. Following the above purchase Mr Stephens has an interest in 1,085,681 OrdinaryShares in the Company, representing 4.04% the Company's issued share capital. Contacts: Tristel plcPaul Swinney, Chief Executive Tel: 01638 721 500 Daniel Stewart & Company PlcGraham Webster Tel: 020 7776 6576 Parkgreen Communications Ltd Tel: 020 7851 7480Lucy Lake Mob: 07894 263 046 lucy.lake@parkgreenmedia.com Notes to Editors Tristel's core business is the marketing of its proprietary chlorine dioxidechemistry that is highly effective in destroying all types of bacteria(including C difficile, MRSA, bacterial spores, and tuberculosis), fungi andviruses and is one of a small group of sporicidal agents that is safe and easyto use. Tristel plc operates with two divisions, Tristel Solutions and TristelTechnologies. Tristel Solutions focuses on infection control products for NHS and privatesector hospitals, primary care trusts, community hospitals, private practices,dental practices and veterinary establishments. The Company's products are usedon instruments, surfaces, and the skin in over 375 UK hospitals, representingsome 60 per cent of all UK NHS Acute & Private Hospitals. Tristel Technologies provides products for Legionella infection control inbuilding water systems and for contamination control in the food growing andfood processing industries. Tristel Technologies has approximately 200 customersin the government, municipal, industrial, healthcare and food sectors and more40 UK hospitals where its products are used for Legionella control. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jul 20177:00 amRNSIssue of Equity
3rd Jul 20171:59 pmRNSStrategic investment
3rd Jul 20177:00 amRNSSubmission to EPA & subsidiary incorporated in USA
13th Jun 20177:00 amRNSIssue of Equity
24th May 20177:00 amRNSShareholder Open Day & Notice of Trading Update
19th May 20173:34 pmRNSIssue of Equity
3rd May 20178:27 amRNSIssue of Equity
7th Apr 20175:04 pmRNSResult of Placing
7th Apr 20172:07 pmRNSProposed Secondary Placing
28th Mar 20172:38 pmRNSIssue of Equity
7th Mar 20179:41 amRNSIssue of Equity
6th Mar 20177:00 amRNSIssue of Equity
27th Feb 20177:00 amRNSProducts approved by Australia's TGA
27th Feb 20177:00 amRNSJournal of Ultrasound in Medicine & Biology
23rd Feb 20177:00 amRNSHalf-year Report
25th Jan 20177:00 amRNSInvestor results presentation
24th Jan 20177:00 amRNSJournal of Infection Prevention: TSTL wipes study
17th Jan 201712:31 pmRNSDirector / PDMR Shareholding
13th Dec 201612:30 pmRNSResult of AGM
13th Dec 20167:00 amRNSAGM Statement
6th Dec 20167:00 amRNSIssue of Equity
28th Nov 20163:42 pmRNSNotice of AGM correction
23rd Nov 201612:37 pmRNSIssue of Equity
17th Oct 20167:00 amRNSFinal Results
13th Oct 20168:33 amRNSIssue of Equity
12th Oct 20168:12 amRNSStudy shows Tristel Wipes System benefits
11th Oct 20167:00 amRNSStudy shows Tristel Wipes System benefits
20th Sep 20167:00 amRNSNotice of Results
19th Sep 20169:24 amRNSIssue of Equity
12th Sep 20167:00 amRNSRegulatory approval in Australia for surface range
19th Aug 20164:30 pmRNSDirector/PDMR Shareholding
19th Aug 20161:30 pmRNSIssue of Equity
21st Jul 20163:26 pmRNSDirector Dealing
21st Jul 20167:00 amRNSTrading update, Special dividend & Acquisition
25th May 20167:00 amRNSShareholder Open Day & Notice of Trading Update
29th Apr 201611:06 amRNSDirector Dealing
26th Apr 201610:06 amRNSDirector Dealing
15th Mar 20167:00 amRNSDirector Dealing
11th Mar 20167:00 amRNSDirector Dealing
10th Mar 20167:00 amRNSDirector Dealing
2nd Mar 20165:13 pmRNSDirector Dealing
2nd Mar 20169:46 amRNSDirector Dealing
29th Feb 20167:00 amRNSDirector Dealing
26th Feb 20169:43 amRNSDirectors Dealings
24th Feb 20167:00 amRNSHalf Yearly Report
25th Jan 20167:00 amRNSNotice of Results
13th Jan 20164:53 pmRNSIssue of Equity
5th Jan 20167:00 amRNSTransition of German branch to subsidiary status
15th Dec 20151:43 pmRNSDirectors Dealings
15th Dec 201512:18 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.